Healthcare provider profile · identity verified

Robert C Cates, MD

Family Practice · BRODHEAD, WI · NPI 1376564898

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	861	237
Lisinopril	Lisinopril	374	102
Levothyroxine Sodium	Levothyroxine Sodium	370	86
Omeprazole	Omeprazole	323	85
Simvastatin	Simvastatin	309	90
Metformin Hcl	Metformin Hcl	277	76
Amlodipine Besylate	Amlodipine Besylate	250	74
Metformin Hcl Er	Metformin Hcl	204	59
Losartan Potassium	Losartan Potassium	203	56
Glipizide Er	Glipizide	197	55
Tamsulosin Hcl	Tamsulosin Hcl	186	49
Hydrochlorothiazide	Hydrochlorothiazide	184	50
Gabapentin	Gabapentin	182	36
Furosemide	Furosemide	171	57
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	164	44
Metoprolol Tartrate	Metoprolol Tartrate	158	40
Metoprolol Succinate	Metoprolol Succinate	134	40
Rosuvastatin Calcium	Rosuvastatin Calcium	133	41
Pantoprazole Sodium	Pantoprazole Sodium	124	40
Albuterol Sulfate Hfa	Albuterol Sulfate	119	46
Atenolol	Atenolol	116	30
Eliquis	Apixaban	108	23
Paroxetine Hcl	Paroxetine Hcl	104	28
Allopurinol	Allopurinol	93	25
Xarelto	Rivaroxaban	91	16
Trazodone Hcl	Trazodone Hcl	86	16
Bupropion Xl	Bupropion Hcl	84	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	17
Prednisone	Prednisone	80	42
Azithromycin	Azithromycin	77	64
Warfarin Sodium	Warfarin Sodium	75	17
Potassium Chloride	Potassium Chloride	73	22
Duloxetine Hcl	Duloxetine Hcl	72	16
Ozempic	Semaglutide	68	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	67	22
Donepezil Hcl	Donepezil Hcl	61	13
Finasteride	Finasteride	57	17
Jardiance	Empagliflozin	56	suppressed
Spironolactone	Spironolactone	54	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	53	15
Cephalexin	Cephalexin	52	38
Ezetimibe	Ezetimibe	51	17
Meloxicam	Meloxicam	51	21
Sertraline Hcl	Sertraline Hcl	51	18
Carvedilol	Carvedilol	50	17
Fluticasone Propionate	Fluticasone Propionate	50	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	22
Triamcinolone Acetonide	Triamcinolone Acetonide	48	35
Alendronate Sodium	Alendronate Sodium	47	17
Farxiga	Dapagliflozin Propanediol	46	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	44	12
Ketoconazole	Ketoconazole	44	23
Ventolin Hfa	Albuterol Sulfate	44	12
Clopidogrel	Clopidogrel Bisulfate	43	15
Montelukast Sodium	Montelukast Sodium	42	13
Citalopram Hbr	Citalopram Hydrobromide	41	12
Mirtazapine	Mirtazapine	40	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	39	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Hydrocortisone	Hydrocortisone	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Dulera	Mometasone/Formoterol	33	suppressed
Glimepiride	Glimepiride	33	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Glipizide	Glipizide	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Amoxicillin	Amoxicillin	31	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	30	30
Baclofen	Baclofen	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	20
Famotidine	Famotidine	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	16
Benazepril Hcl	Benazepril Hcl	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Invokana	Canagliflozin	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Cefuroxime	Cefuroxime Axetil	17	14
Estradiol	Estradiol	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Doxepin Hcl	Doxepin Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Indomethacin	Indomethacin	14	suppressed
Temazepam	Temazepam	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Victoza 2-Pak	Liraglutide	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error